Ciba submits antimicrobials master file

Published: 30-Nov-2006


Ciba Specialty Chemicals has submitted a master file to the Centre for Devices and Radiological Health of the US Food and Drug Administration (FDA) for its silver-based antimicrobials for medical device applications.

The master file can be immediately cross-referenced by marketers and developers of devices containing the novel silver-based technology to support regulatory approvals. The data set contained in the master file includes anticipated device applications, chemistry, and toxicology data along with detailed descriptions of manufacturing, labelling, packaging, and distribution processes and practices and the associated quality controls that are in place. Ciba plans to submit additional master files for related products to the FDA in the future.

HyGentic 4000, a form of elemental silver with distinctive physical properties, was developed by Bio-Gate AG and is distributed globally by Ciba. It is particularly suitable for implanted or inserted medical devices where antimicrobial solutions are increasingly in demand.

You may also like